Innov Clin Neurosci. 2026;23(1–3):47–53. by Hamed Zarei, MD*; Mohammadhossein Vazirizadeh-Mahabadi, MD*; Narges Saadatipour, MD; Maryam Pazhooha, MD; Mostafa Hosseini, PhD; and Mahmoud Yousefifard, PhD *Drs. Zarei and Vazirizadeh-Mahabadi contributed equally
by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Innov Clin Neurosci. 2025;22(10–12):14–23. by Samaneh Ghorbani Shirkouhi, MSc; Seyed Sepehr Khatami, MD; Zohair Niroomand, MD; Saeed Sadigh-Eteghad, PhD; Shahrokh Yousefzadeh-Chabok, MD; and Sasan Andalib, PhD Ms. Ghorbani Shirkouhi is
Innov Clin Neurosci. 2025;22(10–12):24–32. by Mark A. Colijn, MD, MSc, FRCPC, UCNS Dr. Colijn is with the Department of Psychiatry, Mathison Centre for Mental Health Research and Education, and Hotchkiss
